Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02120365 · ClinicalTrials.gov registry record · Phase 1

Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence

A Phase 1 study of Alcoholism, sponsored by Virginia Commonwealth University.

Completed
Registry status
Phase 1
Development phase
22
Enrollment target
4
Study locations

NCT02120365 is a Phase 1 study of Alcoholism that has completed, run by Virginia Commonwealth University. The registered enrollment target is 22 participants, below the 375-participant average among 65 other Alcoholism trials with a reported enrollment target (94% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02120365, a Phase 1 study of Alcoholism, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
Phase 1
Development phase
22 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to determine whether perampanel alters the response to alcohol for heavy drinkers. It is hypothesized that perampanel will reduce the rewarding and reinforcing properties of alcohol in the laboratory setting.

Conditions Studied

Alcoholism

Interventions

  • DRUG Placebo
  • DRUG Perampanel

Study Locations (4)

Connecticut

  • University of Connecticut - Farmington
  • Yale New Haven Hospital Research Unit - New Haven
  • West Haven Veterans Affairs - West Haven

Virginia

  • Albert Arias - Richmond

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2019-06-01
Est. Completion 2022-02-16
Phase Phase 1

Sponsor

Virginia Commonwealth University

558 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02120365

The ClinicalTrials.gov registry entry for NCT02120365 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 375-participant average among 65 other Alcoholism trials with a reported enrollment target (94% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcoholism appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02120365 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Virginia.

Frequently Asked Questions

What is clinical trial NCT02120365 about?

NCT02120365 is a clinical study titled "Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence". The purpose of this study is to determine whether perampanel alters the response to alcohol for heavy drinkers. It is hypothesized that perampanel will reduce the rewarding and reinforcing properties of alcohol in the laboratory setting.

What is the current status of trial NCT02120365?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2019-06-01. Estimated completion is 2022-02-16.

What conditions does trial NCT02120365 study?

This clinical trial studies the following conditions: Alcoholism.

What interventions are being tested in trial NCT02120365?

The interventions under investigation include: Placebo (DRUG), Perampanel (DRUG).

Who is sponsoring clinical trial NCT02120365?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02120365 being conducted?

This trial has 4 study locations across Connecticut, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcoholism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcoholism

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.